Betty Ann Bjerkreim

  • Resident; MD, PhD
 

Publications 2022

Bjerkreim BA, Hammerstad SS, Eriksen EF (2022)
Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy
J Thyroid Res, 2022, 8950546
DOI 10.1155/2022/8950546, PubMed 36248357

Bjerkreim BA, Hammerstad SS, Gulseth HL, Berg TJ, Lee-Ødegård S, Eriksen EF (2022)
Thyroid Signaling Biomarkers in Female Symptomatic Hypothyroid Patients on Liothyronine versus Levothyroxine Monotherapy: A Randomized Crossover Trial
J Thyroid Res, 2022, 6423023
DOI 10.1155/2022/6423023, PubMed 35572853

Bjerkreim BA, Hammerstad SS, Gulseth HL, Berg TJ, Omdal LJ, Lee-Ødegård S, Eriksen EF (2022)
Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study
Front Endocrinol (Lausanne), 13, 816566
DOI 10.3389/fendo.2022.816566, PubMed 35273566

Publications 2021

Bjerkreim BA, Hammerstad SS, Gulseth HL, Berg TJ, Lee-Ødegård S, Rangberg A, Jonassen CM, Budge H, Morris D, Law J, Symonds M, Eriksen EF (2021)
Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study
Front Endocrinol (Lausanne), 12, 785175
DOI 10.3389/fendo.2021.785175, PubMed 34867829